












Hari Bhaskaran
Founder at Cisterna Biologics
Hari Bhaskaran's journey with RNAs started with ribozymes (catalytic RNAs) almost 20 years ago in the labs of Rick Russell at UT Austin. His PhD work was focused on mechanistic understanding of RNA folding, culminating in a seminal publication in Nature (see Bhaskaran and Russell, 2007). Since then, he has held positions of increasing responsibilities in both academia and industry. He is the author of several publications and industry patents.
Follow Hari
Previously at

The Janssen Pharmaceutical Companies of Johnson & Johnson

Arcturus therapeutics
Stratos genomics (acquired by Roche)

The Scripps Research Institute

Oregon Health & Science University
University of california santa barbara
Alumnus of

The University of Texas at Austin